Q2 2025 MedPlus Health Services Ltd Earnings Call Transcript
Key Points
- Medplus Health Services Ltd (BOM:543427) expanded its network to 4,552 pharmacy stores across 680 cities, indicating robust growth.
- The company achieved a net addition of 108 stores in Q2, with a significant focus on tier two cities, highlighting strategic market penetration.
- Private label products now constitute 18.4% of total revenues, showing a positive reception and potential for higher margins.
- Consolidated revenue grew by 11.9% year-on-year, demonstrating strong financial performance.
- The diagnostic segment recorded a significant improvement, with revenue growing to 283.1 million and turning profitable with an operating EBITA of 21 million.
- There were 24 store closures in Q2, which could indicate challenges in certain locations.
- Inventory levels remain high, particularly in new stores, which could impact working capital efficiency.
- The company faces challenges in scaling its private label products due to competition and market dynamics.
- Free cash flow may be impacted by the planned addition of new stores, potentially straining financial resources.
- The tax rate has been volatile, which could affect financial predictability and planning.
Ladies and gentlemen, good day and welcome to the Met Plus Health services limited earnings conference call. As a reminder, all participant lines will be in the listen-only mode and there'll be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during the conference call? Please signal an operator by pressing star and then zero on your Touchstone phone.
Please note that this conference is being recorded.
I now hand the conference over to Mr Sriniva. Thank you and over to you, sir.
Thank you. Good evening, everyone on behalf of Net Plus, it's my utmost pleasure to welcome you all to Net Plus due to F 525 A call to discuss the financial results of Net Plus for the second quarter of F 525 which was announced on 12 November 24.
We have with us today. The senior management team represented by Mr Ma CEO and MD. Mr Sujit Mato CFO and Mr Chetan co.
Before we begin, I would like to mention that some of the statements made in today's discussion
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
